The Scientist

» obituary, evolution and immunology

Most Recent

image: Esteemed Zoologist Dies

Esteemed Zoologist Dies

By | June 1, 2016

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

0 Comments

image: Contributors

Contributors

By | June 1, 2016

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

0 Comments

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

1 Comment

image: Start Making Sense

Start Making Sense

By | June 1, 2016

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

6 Comments

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

2 Comments

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

1 Comment

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

0 Comments

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

1 Comment

image: Population Ecologist Dies

Population Ecologist Dies

By | May 18, 2016

Robert McNeill Alexander, best known for his work on animal locomotion, has passed away aged 81.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech